Rebecca Moody

United States Food and Drug Administration — United States

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

8h-index223citations17works15.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Solubulity and Delivery Systems(7), Analytical Methods in Pharmaceuticals(4), Cancer Cells and Metastasis(3), Pharmaceutical studies and practices(3), Analytical Chemistry and Chromatography(2)

Publications17 total

Using Model Master Files to Support Oral Drug Product Development and Regulatory Submissions
Pharmaceutical Research·2025· 1 cited
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization
Pharmaceutical Research·2025· 11 citedOpen Access
Correction: Leveraging Model Master Files for Long-Acting Injectables
Pharmaceutical Research·2025Open Access
Leveraging Model Master Files for Long-Acting Injectables
Pharmaceutical Research·2025Open Access
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
Molecular Pharmaceutics·2024· 17 citedOpen Access
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
Molecular Pharmaceutics·2024· 20 citedOpen Access
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Molecular Pharmaceutics·2024· 26 citedOpen Access
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
Molecular Pharmaceutics·2024· 49 citedOpen Access
Drug Dissolution in Oral Drug Absorption: Workshop Report
The AAPS Journal·2023· 22 citedOpen Access
Corrigendum to “Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer” [Canc. Lett. 438 (2018, Dec 1) 165–173]
Cancer Letters·2020· 2 cited
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
Cancer Letters·2018· 44 citedOpen Access
Abstract 2004: Identification of MLK4 as a novel regulator of cancer stem cells in triple-negative breast cancer
Cancer Research·2018· 2 cited
Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells
Oncology Reports·2018· 26 citedOpen Access
Abstract 4767: Identifying CDCA7 as a novel regulator of tumor-initiating cells in triple-negative breast cancer
Cancer Research·2017· 2 cited
Abstract 4495: Elucidating BCL11A’s function in triple negative breast cancer
Cancer Research·2017
Use of Intravenous Isoproterenol for Status Asthmaticus in Children
Survey of Anesthesiology·1984
Mescaline: Its effects on learning rate and dopamine metabolism in goldfish (Carassius auratus)
Cellular and Molecular Life Sciences·1976· 1 cited

Frequent Co-authors

Duxin Sun(7), Tycho Heimbach(6), Chang‐Ching Lin(6), Miao‐Chia Lo(6), Nicholas Stevers(6), Samantha L. Tinsley(6), James E. Polli(5), Gregory Rullo(5), Claire Mackie(4), Sumit Arora(4), Xavier Pépin(4), Christer Tannergren(4), Amitava Mitra(4), Luiza Borges(4), Maria Malamatari(4), Shereeni Veerasingham(4), Max S. Wicha(4), Andrew Babiskin(4), Paul Seo(3), Bhagwant Rege(3)